Mylan Faces Patent Suits Over Generic Estradiol
By Jesse Greenspan ( February 24, 2011, 7:19 PM EST) -- Units of Novartis AG and Hisamitsu Pharmaceutical Co. Inc. accused Mylan Inc. of infringing two of their patents by seeking to market a generic estradiol transdermal system in a pair of lawsuits filed this week....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.